Literature DB >> 23867794

Infantile exposure to lead and late-age cognitive decline: relevance to AD.

Syed Waseem Bihaqi1, Azadeh Bahmani2, Gehad M Subaiea1, Nasser H Zawia3.   

Abstract

BACKGROUND: Early-life lead (Pb) exposure induces overexpression of the amyloid beta precursor protein and its amyloid beta product in older rats and primates. We exposed rodents to Pb during different life span periods and examined cognitive function in old age and its impact on biomarkers associated with Alzheimer's disease (AD).
METHODS: Morris, Y, and the elevated plus mazes were used. Western blot, quantitative polymerase chain reaction (qPCR), and enzyme-linked immunosorbent assay were used to study the levels of AD biomarkers.
RESULTS: Cognitive impairment was observed in mice exposed as infants but not as adults. Overexpression of AD-related genes (amyloid beta precursor protein and β-site amyloid precursor protein cleaving enzyme 1) and their products, as well as their transcriptional regulator-specificity protein 1 (Sp1)-occurred only in older mice with developmental exposure to Pb.
CONCLUSIONS: A window of vulnerability to Pb neurotoxicity exists in the developing brain that can influence AD pathogenesis and cognitive decline in old age. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Alzheimer's disease; Cognition; Development; Lead; Life span

Mesh:

Substances:

Year:  2013        PMID: 23867794      PMCID: PMC3864613          DOI: 10.1016/j.jalz.2013.02.012

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  27 in total

1.  Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study.

Authors:  Marc G Weisskopf; Robert O Wright; Joel Schwartz; Avron Spiro; David Sparrow; Antonio Aro; Howard Hu
Journal:  Am J Epidemiol       Date:  2004-12-15       Impact factor: 4.897

Review 2.  Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment.

Authors:  Lyn Patrick
Journal:  Altern Med Rev       Date:  2006-03

3.  Cumulative lead exposure and cognitive performance among elderly men.

Authors:  Marc G Weisskopf; Susan P Proctor; Robert O Wright; Joel Schwartz; Avron Spiro; David Sparrow; Huiling Nie; Howard Hu
Journal:  Epidemiology       Date:  2007-01       Impact factor: 4.822

Review 4.  Amyloid protein and Alzheimer's disease.

Authors:  D J Selkoe
Journal:  Sci Am       Date:  1991-11       Impact factor: 2.142

5.  Alzheimer's disease: The latest suspect.

Authors:  Rudolph E Tanzi; Lars Bertram
Journal:  Nature       Date:  2008-08-07       Impact factor: 49.962

6.  The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.

Authors:  M Riyaz Basha; Wei Wei; Saleh A Bakheet; Nathalie Benitez; Hasan K Siddiqi; Yuan-Wen Ge; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

7.  Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation.

Authors:  Md Riyaz Basha; Manjari Murali; Hasan K Siddiqi; Koyel Ghosal; Omar K Siddiqi; Hilal A Lashuel; Yuan-Wen Ge; Debomoy K Lahiri; N H Zawia
Journal:  FASEB J       Date:  2005-10-17       Impact factor: 5.191

8.  Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis.

Authors:  Brian Brock; Riyaz Basha; Katie DiPalma; Amy Anderson; G Jean Harry; Deborah C Rice; Bryan Maloney; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Alzheimers Dis       Date:  2008-02       Impact factor: 4.472

9.  Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.

Authors:  Jinfang Wu; Md Riyaz Basha; Brian Brock; David P Cox; Fernando Cardozo-Pelaez; Christopher A McPherson; Jean Harry; Deborah C Rice; Bryan Maloney; Demao Chen; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

10.  Protein-DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex.

Authors:  W J Lukiw; E I Rogaev; L Wong; G Vaula; D R McLachlan; P St George Hyslop
Journal:  Brain Res Mol Brain Res       Date:  1994-03
View more
  26 in total

1.  Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: relevance to AD.

Authors:  Syed Waseem Bihaqi; Azadeh Bahmani; Abdu Adem; Nasser H Zawia
Journal:  Neurotoxicology       Date:  2014-06-20       Impact factor: 4.294

2.  Importance of tau in cognitive decline as revealed by developmental exposure to lead.

Authors:  K Wright; S W Bihaqi; A Lahouel; A Masoud; F Mushtaq; A Leso; A Eid; N H Zawia
Journal:  Toxicol Lett       Date:  2017-12-05       Impact factor: 4.372

Review 3.  Epigenetic influence of environmentally neurotoxic metals.

Authors:  Omamuyovwi M Ijomone; Olayemi K Ijomone; Joy D Iroegbu; Chibuzor W Ifenatuoha; Nzube F Olung; Michael Aschner
Journal:  Neurotoxicology       Date:  2020-09-01       Impact factor: 4.294

4.  Lead decreases cell survival, proliferation, and neuronal differentiation of primary cultured adult neural precursor cells through activation of the JNK and p38 MAP kinases.

Authors:  Anna Engstrom; Hao Wang; Zhengui Xia
Journal:  Toxicol In Vitro       Date:  2015-05-09       Impact factor: 3.500

5.  Persistent Effects on Cardiorespiratory and Nervous Systems Induced by Long-Term Lead Exposure: Results from a Longitudinal Study.

Authors:  Liana Shvachiy; Vera Geraldes; Ângela Amaro-Leal; Isabel Rocha
Journal:  Neurotox Res       Date:  2020-01-29       Impact factor: 3.911

6.  Histone acetylation maps in aged mice developmentally exposed to lead: epigenetic drift and Alzheimer-related genes.

Authors:  Aseel Eid; Syed Waseem Bihaqi; Christopher Hemme; John M Gaspar; Ronald P Hart; Nasser H Zawia
Journal:  Epigenomics       Date:  2018-05-03       Impact factor: 4.778

7.  Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.

Authors:  Lina Adwan; Gehad M Subaiea; Nasser H Zawia
Journal:  Neuropharmacology       Date:  2014-01-21       Impact factor: 5.250

8.  Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT.

Authors:  Huiying Gu; Paul R Territo; Scott A Persohn; Amanda A Bedwell; Kierra Eldridge; Rachael Speedy; Zhe Chen; Wei Zheng; Yansheng Du
Journal:  J Trace Elem Med Biol       Date:  2020-09-19       Impact factor: 3.849

9.  Lead exposure disrupts global DNA methylation in human embryonic stem cells and alters their neuronal differentiation.

Authors:  Marie-Claude Senut; Arko Sen; Pablo Cingolani; Asra Shaik; Susan J Land; Douglas M Ruden
Journal:  Toxicol Sci       Date:  2014-02-11       Impact factor: 4.849

Review 10.  Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.

Authors:  Lina Adwan; Nasser H Zawia
Journal:  Pharmacol Ther       Date:  2013-04-03       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.